Frontiers in Immunology (Jan 2023)
Corrigendum: Reliable estimation of CD8 T cell inhibition of in vitro HIV-1 replication
- Yinyan Xu,
- Ann Marie Weideman,
- Ann Marie Weideman,
- Maria Abad-Fernandez,
- Katie R. Mollan,
- Katie R. Mollan,
- Sallay Kallon,
- Shahryar Samir,
- Joanna A. Warren,
- Genevieve Clutton,
- Nadia R. Roan,
- Nadia R. Roan,
- Adaora A. Adimora,
- Adaora A. Adimora,
- Adaora A. Adimora,
- Nancie Archin,
- JoAnn Kuruc,
- Cynthia Gay,
- Michael G. Hudgens,
- Michael G. Hudgens,
- Nilu Goonetilleke,
- Nilu Goonetilleke
Affiliations
- Yinyan Xu
- Department of Microbiology & Immunology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States
- Ann Marie Weideman
- Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
- Ann Marie Weideman
- Center for AIDS Research, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
- Maria Abad-Fernandez
- Department of Microbiology & Immunology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States
- Katie R. Mollan
- Center for AIDS Research, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
- Katie R. Mollan
- Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, United States
- Sallay Kallon
- Department of Microbiology & Immunology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States
- Shahryar Samir
- Department of Microbiology & Immunology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States
- Joanna A. Warren
- Department of Microbiology & Immunology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States
- Genevieve Clutton
- Department of Microbiology & Immunology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States
- Nadia R. Roan
- Department of Urology, University of California San Francisco, San Francisco, CA, United States
- Nadia R. Roan
- Gladstone Institute of Virology and Immunology, San Francisco, CA, United States
- Adaora A. Adimora
- Center for AIDS Research, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
- Adaora A. Adimora
- Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, United States
- Adaora A. Adimora
- School of Medicine and UNC HIV Cure Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States
- Nancie Archin
- School of Medicine and UNC HIV Cure Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States
- JoAnn Kuruc
- School of Medicine and UNC HIV Cure Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States
- Cynthia Gay
- School of Medicine and UNC HIV Cure Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States
- Michael G. Hudgens
- Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
- Michael G. Hudgens
- Center for AIDS Research, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
- Nilu Goonetilleke
- Department of Microbiology & Immunology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States
- Nilu Goonetilleke
- Department of Microbiology & Immunology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States
- DOI
- https://doi.org/10.3389/fimmu.2022.1104661
- Journal volume & issue
-
Vol. 13
